loading
Precedente Chiudi:
$1.90
Aprire:
$1.96
Volume 24 ore:
35,182
Relative Volume:
0.08
Capitalizzazione di mercato:
$9.61M
Reddito:
-
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-0.3946
EPS:
-4.79
Flusso di cassa netto:
$-16.95M
1 W Prestazione:
-2.58%
1M Prestazione:
+3.85%
6M Prestazione:
+263.46%
1 anno Prestazione:
-46.61%
Intervallo 1D:
Value
$1.8519
$1.99
Intervallo di 1 settimana:
Value
$1.83
$2.02
Portata 52W:
Value
$0.4748
$4.25

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name
Nome
Matinas Biopharma Holdings Inc
Name
Telefono
908-443-1860
Name
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Name
Dipendente
15
Name
Cinguettio
@MatinasBio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
MTNB's Discussions on Twitter

Confronta MTNB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MTNB
Matinas Biopharma Holdings Inc
1.89 10.55M 0 -21.13M -16.95M -4.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-05-11 Downgrade Piper Sandler Overweight → Neutral
2020-08-26 Ripresa Piper Sandler Overweight
2020-01-27 Iniziato Piper Sandler Overweight
2020-01-24 Iniziato SunTrust Buy
2020-01-23 Iniziato SunTrust Buy
2020-01-09 Iniziato Aegis Capital Buy
2019-06-26 Iniziato H.C. Wainwright Buy
Mostra tutto

Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie

pulisher
Sep 30, 2025

Why institutional investors increase stakes in Matinas Biopharma Holdings Inc. stock2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Matinas BioPharma Holdings Inc. stock return to pre crisis levelsPrice Action & Precise Trade Entry Recommendations - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Matinas BioPharma Holdings Inc. stock outperform international peersJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

How high can Matinas BioPharma Holdings Inc. stock goPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is Matinas Biopharma Holdings Inc. stock undervalued historicallyWeekly Trend Recap & Community Verified Swing Trade Signals - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Matinas Biopharma Holdings Inc. stock keep high P E multiplesJuly 2025 Update & Consistent Return Strategy Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why Matinas BioPharma Holdings Inc. stock is in analyst buy zone2025 Earnings Impact & Fast Moving Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will Matinas Biopharma Holdings Inc. stock test record highs in 20252025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why millennials buy Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why Matinas BioPharma Holdings Inc. (6LJ0) stock gets analyst attentionDip Buying & Technical Confirmation Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Setups & High Yield Equity Trading Tips - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Ranking Matinas BioPharma Holdings Inc. among high performing stocks via toolsJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How to build a custom watchlist for Matinas BioPharma Holdings Inc.Trend Reversal & Capital Protection Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Can trapped investors hope for a rebound in Matinas BioPharma Holdings Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Understanding Matinas BioPharma Holdings Inc.’s price movementEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What to expect from Matinas BioPharma Holdings Inc. in the next 30 daysJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Why retail traders accumulate Matinas BioPharma Holdings Inc. (6LJ0) stockEarnings Overview Report & Low Drawdown Trading Techniques - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How Matinas Biopharma Holdings Inc. stock moves in volatile trading sessions2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Can Matinas BioPharma Holdings Inc. stock attract ESG capital inflowsJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Matinas BioPharma Holdings Inc. stock a dividend growth opportunity - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Will Matinas Biopharma Holdings Inc. stock outperform energy sector in 2025Weekly Investment Recap & Entry Point Confirmation Alerts - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Matinas BioPharma Holdings Inc stock priceTrendline Breakouts & High Return Stock Ideas - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Matinas BioPharma Holdings Inc 6LJ0 Stock Analysis and ForecastTrading Volume Surges & Double Or Triple Profits - earlytimes.in

Sep 28, 2025

Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Capitalizzazione:     |  Volume (24 ore):